☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Hemolysis Patients
Sanofi's Sutimlimab Receives the US FDA's Priority Review to Treat Hemolysis Patients with Cold Agglutinin Disease
May 14, 2020
Load more...
Back to Home